Washington: PATH Gets Gates Grant of $27.8 Million to Improve Access to Cancer Vaccine
June 7, 2006
On Monday, the Seattle-based non-profit Program for Appropriate Technology in Health (PATH) announced it had received a grant from the Bill & Melinda Gates Foundation to identify and overcome obstacles to distributing a human papillomavirus vaccine in poor nations. Two types of HPV are believed to cause 70 percent of cervical cancer cases. "Cervical cancer disproportionately affects women in developing countries because infrastructure is lacking," said Dr. Jacqueline Sherris, director of the cervical cancer program at PATH. Together with the World Health Organization and drug makers Merck and GlaxoSmithKline, PATH will conduct research to reduce barriers to the HPV vaccine in India, Peru, Uganda and Vietnam.
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.